ESR1 and breast carcinoma: In particular, treatment with tamoxifen induces the nuclear translocation of the ERα36 receptor, which directly regulates the transcription of ALDH1A1, suggesting a genomic-type mechanism of action in stem/progenitor cells of ER-positive breast cancers (29, 74).